Table of Contents Author Guidelines Submit a Manuscript
AIDS Research and Treatment
Volume 2015, Article ID 478750, 7 pages
http://dx.doi.org/10.1155/2015/478750
Research Article

Fructosamine and Hemoglobin A1c Correlations in HIV-Infected Adults in Routine Clinical Care: Impact of Anemia and Albumin Levels

1University of Washington, Seattle, WA 98195, USA
2University of Alabama at Birmingham, Birmingham, AL 35294, USA

Received 10 April 2015; Revised 4 June 2015; Accepted 10 June 2015

Academic Editor: Glenda Gray

Copyright © 2015 Luisa Duran et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. J. Palella Jr., K. M. Delaney, A. C. Moorman et al., “Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators,” The New England Journal of Medicine, vol. 338, no. 13, pp. 853–860, 1998. View at Google Scholar
  2. E. L. Murphy, A. C. Collier, L. A. Kalish et al., “Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease,” Annals of Internal Medicine, vol. 135, no. 1, pp. 17–26, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. R. S. Hogg, K. V. Heath, B. Yip et al., “Improved survival among HIV-infected individuals following initiation of antiretroviral therapy,” Journal of the American Medical Association, vol. 279, no. 6, pp. 450–454, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Carr, K. Samaras, A. Thorisdottir, G. R. Kaufmann, D. J. Chisholm, and D. A. Cooper, “Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study,” The Lancet, vol. 353, no. 9170, pp. 2093–2099, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Behrens, A. Dejam, H. Schmidt et al., “Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors,” AIDS, vol. 13, no. 10, pp. F63–F70, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. P. C. Tien, M. F. Schneider, S. R. Cole et al., “Antiretroviral therapy exposure and incidence of diabetes mellitus in the Women's Interagency HIV Study,” AIDS, vol. 21, no. 13, pp. 1739–1745, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. W. M. El-Sadr, C. M. Mullin, A. Carr et al., “Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral-naïve cohort,” HIV Medicine, vol. 6, no. 2, pp. 114–121, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. The International Expert Committee, “International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes,” Diabetes Care, vol. 32, no. 7, pp. 1327–1334, 2009. View at Publisher · View at Google Scholar
  9. D. B. Sacks, M. Arnold, G. L. Bakris et al., “Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus,” Diabetes Care, vol. 34, no. 6, pp. e61–e99, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. L. A.-C. Wright and I. B. Hirsch, “The challenge of the use of glycemic biomarkers in diabetes: reflecting on hemoglobin A1C, 1,5-anhydroglucitol, and the glycated proteins fructosamine and glycated albumin,” Diabetes Spectrum, vol. 25, no. 3, pp. 141–148, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. P. M. Polgreen, D. Putz, and J. T. Stapleton, “Inaccurate glycosylated hemoglobin A1C measurements in human immunodeficiency virus-positive patients with diabetes mellitus,” Clinical Infectious Diseases, vol. 37, no. 4, pp. e53–e56, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. M.-E. Diop, J.-P. Bastard, N. Meunier et al., “Inappropriately low glycated hemoglobin values and hemolysis in HIV-infected patients,” AIDS Research and Human Retroviruses, vol. 22, no. 12, pp. 1242–1247, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. P. S. Kim, C. Woods, P. Georgoff et al., “A1C underestimates glycemia in HIV infection,” Diabetes Care, vol. 32, no. 9, pp. 1591–1593, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. S.-Y. Kim, P. Friedmann, A. Seth, and A. M. Fleckman, “Monitoring HIV-infected patients with diabetes: hemoglobin A1c, fructosamine, or glucose?” Clinical Medicine Insights: Endocrinology and Diabetes, vol. 7, pp. 41–45, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. D. A. Armbruster, “Fructosamine: structure, analysis, and clinical usefulness,” Clinical Chemistry, vol. 33, no. 12, pp. 2153–2163, 1987. View at Google Scholar · View at Scopus
  16. R. Weber, C. A. Sabin, N. Friis-Moller et al., “Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study,” Archives of Internal Medicine, vol. 166, no. 15, pp. 1632–1641, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. M. M. Kitahata, B. Rodriguez, R. Haubrich et al., “Cohort profile: the centers for AIDS research network of integrated clinical systems,” International Journal of Epidemiology, vol. 37, no. 5, pp. 948–955, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. “Standards of medical care in diabetes—2012,” Diabetes Care, vol. 35, supplement 1, pp. S11–S63, 2011. View at Publisher · View at Google Scholar
  19. M. P. Van Dieijen-Visser, C. Seynaeve, and P. J. Brombacher, “Influence of variations in albumin or total-protein concentration on serum fructosamine concentration,” Clinical Chemistry, vol. 32, no. 8, article 1610, 1986. View at Google Scholar · View at Scopus
  20. J. E. A. Howey, M. C. K. Browning, and C. G. Fraser, “Assay of serum fructosamine that minimizes standardization and matrix problems: use to assess components of biological variation,” Clinical Chemistry, vol. 33, no. 2, pp. 269–272, 1987. View at Google Scholar · View at Scopus
  21. S. E. Kellerman, D. L. Hanson, A. D. McNaghten, and P. L. Fleming, “Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects,” The Journal of Infectious Diseases, vol. 188, no. 4, pp. 571–577, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. C. S. Graham, L. R. Baden, E. Yu et al., “Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis,” Clinical Infectious Diseases, vol. 33, no. 4, pp. 562–569, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. R. M. Cohen and C. J. Lindsell, “When the blood glucose and the HbA1c don't match: turning uncertainty into opportunity,” Diabetes Care, vol. 35, no. 12, pp. 2421–2423, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. R. M. Cohen, S. Haggerty, and W. H. Herman, “HbA1c for the diagnosis of diabetes and prediabetes: is it time for a mid-course correction?” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 12, pp. 5203–5206, 2010. View at Publisher · View at Google Scholar · View at Scopus